Literature DB >> 22718103

Differential effect of oxidative stress on intestinal apparent permeability of drugs transported by paracellular and transcellular route.

Pankaj Dixit1, Dinesh Kumar Jain, Jaypal Singh Rajpoot.   

Abstract

Increased intestinal permeability of macromolecules is a common feature of oxidative stress-induced gastrointestinal diseases; how it affects the absorption of drugs is not investigated. Hence, it was proposed to study the influence of hydrogen peroxide-induced oxidative stress on permeability of atenolol and metoprolol using a modified everted rat intestine technique. Atenolol was chosen as a marker of paracellular drug transport and metoprolol was selected to represent transcellular drug transport. Wistar rats were used as a source of intestine, which was everted using a glass rod, mounted on permeability apparatus, having test drug (100 μg/ml in Krebs) in donor compartment. Samples were taken from receiver compartment every 5 min for 60 min, and analyzed by HPLC. For induction of oxidative stress isolated ileum was incubated in H₂O₂ (200 μM) containing Krebs for 15 min and then again permeability was estimated. Extent of oxidative stress was determined by estimating lipid peroxidation using thiobarbituric acid assay, which was found to be increased by 42 % in hydrogen peroxide treated rat intestine as compared to control group. The mean apparent permeability of atenolol and metoprolol was found to be 0.054 ± 0.024 × 10⁻⁴ and 0.84 ± 0.14 × 10⁻⁴ cm/s, respectively, in control group rat intestinal segments. After exposure to hydrogen peroxide, there was a significant increase in the mean permeability of atenolol (0.11 ± 0.01 × 10⁻⁴ cm/s), however, metoprolol permeability was unaltered (0.94 ± 0.047 × 10⁻⁴ cm/s). The marked increase in the apparent permeability of atenolol may be attributed to rupture of intestinal barrier. In conclusion, the present study reports the differential effect of oxidative stress-induced damage on drug transport across rat intestine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22718103     DOI: 10.1007/s13318-012-0099-4

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  23 in total

Review 1.  Intestinal epithelial hyperpermeability: update on the pathogenesis of gut mucosal barrier dysfunction in critical illness.

Authors:  Mitchell P Fink
Journal:  Curr Opin Crit Care       Date:  2003-04       Impact factor: 3.687

2.  Inflammatory reaction without endogenous antioxidant response in Caco-2 cells exposed to iron/ascorbate-mediated lipid peroxidation.

Authors:  Sandra Bernotti; Ernest Seidman; Daniel Sinnett; Sylvain Brunet; Serge Dionne; Edgard Delvin; Emile Levy
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-07-03       Impact factor: 4.052

3.  A possibility to predict the absorbability of poorly water-soluble drugs in humans based on rat intestinal permeability assessed by an in vitro chamber method.

Authors:  Etsushi Watanabe; Masayuki Takahashi; Masahiro Hayashi
Journal:  Eur J Pharm Biopharm       Date:  2004-11       Impact factor: 5.571

4.  Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability.

Authors:  A Alhamoruni; A C Lee; K L Wright; M Larvin; S E O'Sullivan
Journal:  J Pharmacol Exp Ther       Date:  2010-06-30       Impact factor: 4.030

5.  Beta-adrenoceptor blockers and the blood-brian barrier.

Authors:  G Neil-Dwyer; J Bartlett; J McAinsh; J M Cruickshank
Journal:  Br J Clin Pharmacol       Date:  1981-06       Impact factor: 4.335

6.  Validation of a differential in situ perfusion method with mesenteric blood sampling in rats for intestinal drug interaction profiling.

Authors:  Joachim Brouwers; Raf Mols; Pieter Annaert; Patrick Augustijns
Journal:  Biopharm Drug Dispos       Date:  2010-07       Impact factor: 1.627

7.  Role of free radicals and poly(ADP-ribose) synthetase in intestinal tight junction permeability.

Authors:  S Cuzzocrea; E Mazzon; A De Sarro; A P Caputi
Journal:  Mol Med       Date:  2000-09       Impact factor: 6.354

8.  Scaling of in vitro membrane permeability to predict P-glycoprotein-mediated drug absorption in vivo.

Authors:  Yoshiyuki Shirasaka; Yoshie Masaoka; Makoto Kataoka; Shinji Sakuma; Shinji Yamashita
Journal:  Drug Metab Dispos       Date:  2008-02-14       Impact factor: 3.922

9.  Effects of cadmium on glutathione peroxidase, superoxide dismutase, and lipid peroxidation in the rat heart: a possible mechanism of cadmium cardiotoxicity.

Authors:  I S Jamall; J C Smith
Journal:  Toxicol Appl Pharmacol       Date:  1985-08       Impact factor: 4.219

10.  Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability.

Authors:  P D Cani; S Possemiers; T Van de Wiele; Y Guiot; A Everard; O Rottier; L Geurts; D Naslain; A Neyrinck; D M Lambert; G G Muccioli; N M Delzenne
Journal:  Gut       Date:  2009-02-24       Impact factor: 23.059

View more
  3 in total

1.  N-Acetylcysteine protects against intrauterine growth retardation-induced intestinal injury via restoring redox status and mitochondrial function in neonatal piglets.

Authors:  Hao Zhang; Yue Li; Yueping Chen; Lili Zhang; Tian Wang
Journal:  Eur J Nutr       Date:  2018-12-10       Impact factor: 5.614

2.  Spirulina platensis alleviates chronic inflammation with modulation of gut microbiota and intestinal permeability in rats fed a high-fat diet.

Authors:  Ting Yu; Yan Wang; Xiaosu Chen; Wenjie Xiong; Yurong Tang; Lin Lin
Journal:  J Cell Mol Med       Date:  2020-07-07       Impact factor: 5.310

Review 3.  Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury.

Authors:  Shishi Liao; Jie Luo; Tulanisa Kadier; Ke Ding; Rong Chen; Qingtao Meng
Journal:  Front Pharmacol       Date:  2022-03-16       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.